Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

A new gene, JMJD1C, may affect testosterone levels in men.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

CEC levels may be a useful marker for predicting prostate cancer progression.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Serum triglyceride levels are not linked to prostate cancer risk.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Testosterone therapy increases bone density in older men with low testosterone levels.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Dutasteride reduces DHT more effectively than finasteride.

Hair loss gene linked to prostate issues.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Finasteride effectively treats baldness but may cause sexual side effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

No definitive link between finasteride and male breast cancer, but further research is needed.

Hair transplantation for men has improved, offering natural, lasting results, and may be enhanced by certain medications and future technologies.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.